Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
Sangamo BioSciences, Inc. - Common Stock   (ticker: SGMO)
Quote:Sangamo Therapeutics Inc.(SGMO) SGMO Quotes on: Yahoo | Google
9.93
0.26 (2.552%)
5 day's Perf: 179.71%
1 Month Perf: 225.57%
3 Month Perf: 183.71%
YTD Perf: 225.57%
1 Year Perf: 72.39%
Stock chart
Useful Quick Links for SGMO
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :       Strong Sell       (Click Here For Details)
INSIDERS' Score: 10
0 100 10
BuySell
Latest 1 month: 0 0
Latest 6 Months: 0 35,000
52 Weeks: 11,408 90,000
Gurus' Indicator :       Strong Buy       (Click Here For Details)
GURUS' Score: 100
0 100 100
Current Holdings: 2,010,580
Previous Holdings: 946,668
Change: 112.38%
Institutions' Indicator :          Hold          (Click Here For Details)
INSTITUTIONS' Score: 50
0 100 50
Current Holdings: 69,236,490
Previous Holdings: 65,682,017
Change: 5.41%
News And Links For The Group (Contribute a link)
[SGMO]   Ionis's Spinraza Still Bests Novartis's Zolgensma  (Seeking Alpha)   22-Apr-19 10:40
[SGMO]   Sangamo 2018: Coming Up Short  (Seeking Alpha)   6-Mar-19 15:40
[SGMO]   Sangamo: A Competitive Intelligence Report On Empowers And Champions  (Seeking Alpha)   18-Feb-19 14:13
[SGMO]   bluebird bio's Pricing Strength Expands Their Potential  (Seeking Alpha)   5-Feb-19 10:00
[SGMO]   Week 6 Breakout Forecast: Short-Term Picks To Give You An Edge  (Seeking Alpha)   3-Feb-19 22:22
[SGMO]   Genomic Medicine 2019: Sangamo Assay Kicks Off A Pivotal Year  (Seeking Alpha)   3-Jan-19 15:08
[SGMO]   Denali Follows Up First-Mover Advantage In LRRK2 With Sanofi Deal To Evaluate RIPK1 Inhibitors  (Seeking Alpha)   5-Nov-18 08:56
[SGMO]   Bulletproof Investing Performance Update: Week 48  (Seeking Alpha)   28-Oct-18 14:22
[SGMO]   Peculiar Financial Moves For Crispr: Are These Red Flags?  (Seeking Alpha)   4-Oct-18 09:15
[SGMO]   LogicBio Therapeutics Starts U.S. IPO Process  (Seeking Alpha)   28-Sep-18 13:01
[SGMO]   The Sangamo Sell-Off And Amarin's Pending Trial - The Idea Guide  (Seeking Alpha)   14-Sep-18 14:30
[SGMO]   In-Depth Analysis Of SB-913 Early Clinical Readout For MPS II  (Seeking Alpha)   11-Sep-18 05:59
[SGMO]   Sangamo (Part V): Assessing The Prospects Of SB-913  (Seeking Alpha)   11-Sep-18 04:14
[SGMO]   Sangamo: It Worked, Didn't It?  (Seeking Alpha)   10-Sep-18 17:57
[SGMO]   Sangamo: Did It Work?  (Seeking Alpha)   7-Sep-18 17:59
[SGMO]   Sangamo Tumbles On MPS II Data, But It Was Grossly Misunderstood  (Seeking Alpha)   7-Sep-18 11:02
[SGMO]   Your Daily Pharma Scoop: Novocure's Mesothelioma Success, Sangamo's Mixed Results, China's First Homegrown Onco Med  (Seeking Alpha)   6-Sep-18 16:09
[SGMO]   Sangamo Therapeutics: More Catalysts Powering A Gene-Based Innovator  (Seeking Alpha)   18-Aug-18 21:34
[SGMO]   Spark Therapeutics: This Appears To Be A Dip Worth Buying  (Seeking Alpha)   14-Aug-18 10:35
[SGMO]   Sangamo's Acquisition Of TxCell Is A Double Edged Sword  (Seeking Alpha)   23-Jul-18 21:10
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*